Biolase | 合法醫療器材資訊網

BIOLASE,Inc.(NASDAQ:BIOL),thegloballeaderindentallasers,todayannouncedthatitwillreleasefirstquarter2021financialandoperatingresultson​ ...

PR Newswire

BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASEs Series J Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $100.00 per share (the "Series J Convertible Preferred Stock"), and one warrant (the "Warrants") to purchase one-half of one (0.5